Serum n-6 polyunsaturated fatty acids, Δ5- and D6-desaturase activities, and risk of incident type 2 diabetes in men: The Kuopio Ischaemic Heart Disease Risk Factor Study

American Journal of Clinical Nutrition

Volumn 103, Issue 5, 2016, Pages 1337-1343

  Yary, Teymoor ^a   Voutilainen, Sari ^a   Tuomainen, Tomi Pekka ^a   Ruusunen, Anu ^b   Nurmi, Tarja ^a   Virtanen, Jyrki K ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Desaturase enzymes; Polyunsaturated fatty acids; Prospective study; Serum zinc; Type 2 diabetes

Indexed keywords

ACYL COENZYME A DESATURASE 1; DIHOMO GAMMA LINOLENIC ACID; GAMMA LINOLENIC ACID; GLUCOSE; LINOLEOYL COENZYME A DESATURASE; POLYUNSATURATED FATTY ACID; ZINC; ARACHIDONIC ACID; LINOLEIC ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; ENZYME ACTIVITY; FATTY ACID METABOLISM; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; ZINC BLOOD LEVEL; BLOOD; FOLLOW UP; GLUCOSE TOLERANCE TEST; HEART MUSCLE ISCHEMIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

8,11,14-EICOSATRIENOIC ACID; ADULT; ARACHIDONIC ACID; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, OMEGA-6; FINLAND; FOLLOW-UP STUDIES; GAMMA-LINOLENIC ACID; GLUCOSE TOLERANCE TEST; HUMANS; LINOLEIC ACID; LINOLEOYL-COA DESATURASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; ZINC;

EID: 84969540978     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.128629     Document Type: Article

References (39)

1. Rhodes ET, Prosser L, Hoerger T, Lieu T, Ludwig D, Laffel L. Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus. Diabet Med 2012;29:453-63.
2. Herman WH, Zimmet P. Type 2 diabetes: An epidemic requiring global attention and urgent action. Diabetes Care 2012;35:943-4.
3. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009;48:44-51.
4. Arab L. Biomarkers of fat and fatty acid intake. J Nutr 2003;133:925S- 32S.
5. Murff HJ, Edwards TL. Endogenous production of long-chain polyunsaturated fatty acids and metabolic disease risk. Curr Cardiovasc Risk Rep 2014;8:418.
6. Kröger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, Joost HG, Boeing H, Schulze MB. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011;93:127-42.
7. Alhazmi A, Stojanovski E, Garg ML, McEvoy M. Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: A nested case control study. PLoS One 2014;9:e97001.
8. Lankinen MA, Stancáková A, Uusitupa M, Agren J, Pihlajamäki J, Kuusisto J, Schwab U, Laakso M. Plasma fatty acids as predictors of glycaemia and type 2 diabetes. Diabetologia 2015;58:2533-44.
9. Mahendran Y, Cederberg H, Vangipurapu J, Kangas AJ, Soininen P, Kuusisto J, Uusitupa M, Ala-Korpela M, Laakso M. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care 2013;36:3732-8.
10. Mahendran Y, Agren J, Uusitupa M, Cederberg H, Vangipurapu J, Stancakova A, Schwab U, Kuusisto J, Laakso M. Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am J Clin Nutr 2014;99:79-85.
11. Hodge AM, English DR, O'Dea K, Sinclair AJ, Makrides M, Gibson RA, Giles GG. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007;86:189-97.
12. Takkunen MJ, Schwab US, de Mello VD, Eriksson JG, Lindström J, Tuomilehto J, Uusitupa MI; DPS Study Group. Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study. Eur J Nutr 2015 May 1 (Epub ahead of print; DOI:10.1007/s00394-015-0911-4).
13. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH, ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003;78:91-8.
14. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994;43:1353-7.
15. Harris WS, Shearer GC. Omega-6 fatty acids and cardiovascular disease: friend, not foe? Circulation 2014;130:1562-4.
16. Laaksonen DE, Lakka T, Lakka H, Nyyssönen K, Rissanen T, Niskanen L, Salonen JT. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 2002;19:456-64.
17. Russo C, Olivieri O, Girelli D, Guarini P, Pasqualini R, Azzini M, Corrocher R. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension 1997;29:1058-63.
18. Yary T, Virtanen JK, Ruusunen A, Tuomainen T, Voutilainen S. Serum zinc and risk of type 2 diabetes incidence in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. J Trace Elem Med Biol 2016;33:120-4.
19. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 1988;20:46-50.
20. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
21. Lakka TA, Venalainen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994;330: 1549-54.
22. Kauhanen J, Julkunen J, Salonen JT. Coping with inner feelings and stress: heavy alcohol use in the context of alexithymia. Behav Med 1992;18:121-6.
23. Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease Risk Factor Study. Circulation 2001;103:2674-80.
24. Wallace TM, Matthews D. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.
25. Salonen JT, Salonen R, Seppanen K, Kantola M, Suntioinen S, Korpela H. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. BMJ 1991;302:756-60.
26. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 2003;126:1-27.
27. Das UN. A defect in D6 and D5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians. Lipids Health Dis 2010;9: 130.
28. Bruneau C, Staedel-Flaig C, Crémel G, Leray C, Beck J, Hubert P. Influence of lipid environment on insulin binding in cultured hepatoma cells. Biochim Biophys Acta 1987;928:287-96.
29. Summers LK, Fielding B, Bradshaw H, Ilic V, Beysen C, Clark M, Moore N, Frayn K. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002;45:369-77.
30. Perreault M, Roke K, Badawi A, Nielsen DE, Abdelmagid SA, El- Sohemy A, Ma DW, Mutch DM. Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults. Lipids 2014;49:255-63.
31. Patel PS, Sharp SJ, Jansen E, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Fatty acids measured in plasma and erythrocytemembrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: A pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010;92:1214-22.
32. Suresh Y, Das U. Protective action of arachidonic acid against alloxaninduced cytotoxicity and diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 2001;64:37-52.
33. Krishna Mohan I, Das U. Prevention of chemically induced diabetes mellitus in experimental animals by polyunsaturated fatty acids. Nutrition 2001;17:126-51.
34. Kapoor R, Huang Y. Gamma linolenic acid: An antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol 2006;7:531-4.
35. Krachler B, Norberg M, Eriksson JW, Hallmans G, Johansson I, Vessby B, Weinehall L, Lindahl B. Fatty acid profile of the erythrocyte membrane preceding development of type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008;18:503-10.
36. Kurotani K, Sato M, Ejima Y, Nanri A, Yi S, Pham NM, Akter S, Poudel-Tandukar K, Kimura Y, Imaizumi K. High levels of stearic acid, palmitoleic acid, and dihomo-g-linolenic acid and low levels of linoleic acid in serum cholesterol ester are associated with high insulin resistance. Nutr Res 2012;32:669-75.e3.
37. Kröger J, Schulze MB. Recent insights into the relation of Delta5 desaturase and Delta6 desaturase activity to the development of type 2 diabetes. Curr Opin Lipidol 2012;23:4-10.
38. Tosi F, Sartori F, Guarini P, Olivieri O, Martinelli N. Delta-5 and Delta- 6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease. Adv Exp Med Biol 2014;824:61-81.
39. Huang YS, Cunnane S, Horrobin D, Davignon J. Most biological effects of zinc deficiency corrected by g-linolenic acid (18:3v6) but not by linoleic acid (18:2v6). Atherosclerosis 1982;41:193-207.